AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Gensana, M Altisent, C Aznar, JA Casana, P Hernandez, F Jorquera, JI Magallon, M Massot, M Puig, L
Citation: M. Gensana et al., Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII, HAEMOPHILIA, 7(4), 2001, pp. 369-374

Authors: Vidal, F Farssac, E Altisent, C Puig, L Gallardo, D
Citation: F. Vidal et al., Rapid hemophilia a molecular diagnosis by a simple DNA sequencing procedure: Identification of 14 novel mutations (vol 85, pg 580, 2001), THROMB HAEM, 86(2), 2001, pp. 727-727

Authors: Vidal, F Farssac, E Altisent, C Puig, L Gallardo, D
Citation: F. Vidal et al., Rapid hemophilia A molecular diagnosis by a simple DNA sequencing procedure: Identification of 14 novel mutations, THROMB HAEM, 85(4), 2001, pp. 580-583

Authors: Sauleda, S Juarez, A Esteban, JI Altisent, C Ruiz, I Puig, L Esteban, R Guardia, J
Citation: S. Sauleda et al., Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders, HEPATOLOGY, 34(5), 2001, pp. 1035-1040

Authors: Galan, AM Tonda, R Altisent, C Maragall, S Ordinas, A Escolar, G
Citation: Am. Galan et al., Recombinant factor VIIa (NovoSeven (R)) restores deficient coagulation: Experience from an ex vivo model, SEM HEMATOL, 38(4), 2001, pp. 10-14

Authors: Lorenzo, JI Lopez, A Altisent, C Aznar, JA
Citation: Ji. Lorenzo et al., Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age, BR J HAEM, 113(3), 2001, pp. 600-603

Authors: Sauleda, S Esteban, JI Altisent, C Puig, L Esteban, R Guardia, J
Citation: S. Sauleda et al., Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C, THROMB HAEM, 83(6), 2000, pp. 807-810

Authors: Briones, C Mas, A Gomez-Mariano, G Altisent, C Menedez-Arias, L Soriano, V Domingo, E
Citation: C. Briones et al., Dynamics of dominance of a dipeptide insertion in reverse transcriptase ofHIV-1 from patients subjected to prolonged therapy, VIRUS RES, 66(1), 2000, pp. 13-26

Authors: Babiker, A Darby, S De Angelis, D Kwart, D Porter, K Beral, V Darbyshire, J Day, N Gill, N Coutinho, R Prins, M van Benthem, B Coutinho, R Dabis, F Marimoutou, C Ruiz, I Tusell, J Altisent, C Evatt, B Jaffe, H Kirk, O Pedersen, C Rosenberg, P Goedert, J Biggar, R Melbye, M Brettie, R Downs, A Hamouda, O Touloumi, G Karafoulidou, A Katsarou, O Donfield, S Gomperts, E Hilgartner, M Hoots, K Schoenbaum, E Beral, V Zangerle, R Del Amo, J Pezzotti, P Rezza, G Hutchinson, S Day, N De Angelis, D Gore, S Kingsley, L Schrager, L Rosenberg, P Goedert, J Melnick, S Koblin, B Eskild, A Bruun, J Sannes, M Evans, B Lepri, AC Sabin, C Buchbinder, S Vittinghoff, E Moss, A Osmond, D Winkelstein, W Goldberg, D Boufassa, F Meyer, L Egger, M Francioli, P Rickenbach, M Cooper, D Tindall, B Sharkey, T Vizzard, J Kaldor, J Cunningham, P Vanhems, P Vizzard, J Kaldor, J Learmont, J Farewell, V Berglund, O Mosley, J Operskalski, E van den Berg, M Metzger, D Tobin, D Woody, G Rusnak, J Hendrix, C Garner, R Hawkes, C Renzullo, P Garland, F Darby, S Ewart, D Giangrande, P Lee, C Phillips, A Spooner, R Wilde, J Winter, M Babiker, A Darbyshire, J Evans, B Gill, N Johnson, A Phillips, A Porter, K Lorenzo, JI Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137

Authors: Barretina, J Blanco, J Gutierrez, A Puig, L Altisent, C Espanol, T Caragol, I Clotet, B Este, JA
Citation: J. Barretina et al., Evaluation of the putative role of C-C chemokines as protective factors ofHIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives, TRANSFUSION, 40(4), 2000, pp. 461-467

Authors: Vidal, F Farssac, E Altisent, C Puig, L Gallardo, D
Citation: F. Vidal et al., Factor IX gene sequencing by a simple and sensitive 15-hour procedure for haemophilia B diagnosis: identification of two novel mutations, BR J HAEM, 111(2), 2000, pp. 549-551

Authors: Vidal, F Farssac, E Altisent, C Puig, L Gallardo, D
Citation: F. Vidal et al., A novel mutation (2409delT) in exon 14 of the factor VIII gene causes severe haemophilia A, HUMAN HERED, 50(4), 2000, pp. 266-267

Authors: Montoro, JB Altisent, C Pico, M Cabanas, MJ Vila, M Puig, LL
Citation: Jb. Montoro et al., Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor (vol 4, pg 762, 1998), HAEMOPHILIA, 5(5), 1999, pp. 371-371

Authors: Tassies, D Magallon, M Quintana, M Fernandez-Urgelles, M Rodriguez-Pinto, C Tusell, J Altisent, C Reverter, JC Mazzara, R Ordinas, A Monteagudo, J
Citation: D. Tassies et al., Hepatitis G virus infection markers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacs, HAEMATOLOG, 84(10), 1999, pp. 930-936

Authors: Vallejo, A Mas, A Heredia, A Altisent, C Lorenzo, I Soriano, V Hewlett, IK
Citation: A. Vallejo et al., V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohortwith long-term non-progressive infection, AIDS, 13(4), 1999, pp. 532-534
Risultati: 1-15 |